Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Finance · ·
$8.76
▲ $0.07 (+0.7%)
Market data updated: 09/24 07:07 PM
Fundamentals updated: 09/24/2026
News analyzed: 09/24/2026
Market Cap
$158.48M
Day Range
$8.62 - $8.83
52-Week Range
$7.31 - $11.71
Beta
—
Next Earnings
15.10.2026
Support
$8.11
Resistance
$10.74
+0.2% (1Y)
Strengths: 8/22 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🟡 Mixed
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
DCF Fair Value
Estimated fair value: $37.85 vs. price $8.76 (+332.4%)
Fair Value
Biggest negative driver
Calmar Ratio (return vs. drawdown)
Calmar: -0.19 (3y annualized return -8.6% / max drawdown 45.3%)
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 3 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 3
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
42
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
32
Quality
No data available
Value
67
Momentum
49
Risk
42
Sentiment
0
Fundamental
42
Institutional
100
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of BCB Bancorp, Inc. has primarily centered on its Q2 2026 earnings performance, where the company reported a loss and missed revenue estimates, drawing attention to financial challenges. Additionally, the bank filed a $100 million mixed shelf prospectus to raise capital through common stock, preferred stock, debt, and other securities, signaling efforts to bolster liquidity or growth. The broader banking sector saw gains in July, contrasting with BCB’s underperformance.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about BCB Bancorp, Inc. (NJ). News trend score: 0. Reason: 18 of the last 20 articles are negative, versus 0 positive.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
32
🎯 Conviction (vs. Emotion)
50
Psychology
43
Fundamentals
42
Technical
49
Valuation
67
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
A significant decline over time, but on unusually low trading volume — holders unwilling to accept the loss.
The price rise has far outpaced the actual improvement in fundamental data.
Price (3M)
-16%
Market Narrative
13
Fundamental Reality
50
Narrative Gap
-37
🔀 Weak-Conviction Rally
Price is moving, but not accompanied by a matching rise in news attention/sentiment.
🧠 StockIQ Psychologist
Market behavior suggests traders are anchored near support (3.0% above) while loss aversion dominates, reflecting reluctance to accept deeper declines after a 22.9% drop. The narrative gap (-38) hints at a disconnect where fundamentals (realityScore 50) outpace market perception (narrativeScore 12), possibly amplifying defensive positioning. Herding remains muted, as the stock’s outperformance today contrasts with peer weakness. The key question: will traders hold near support or break below it, given the extreme valuation gap and lack of momentum?
Updated: 09/07/2026, 11:10 AM
What could change this?
👥 What the crowd believes
"BCB Bancorp (BCBP) Reports Q2 Loss, Misses Revenue Estimates"
"BCB Bancorp, Inc. is downgraded to Sell after ... surging credit losses"
"BCB Bancorp, Inc. is downgraded to Sell after ... dividend suspension"
"Board Approves Reincorporation in Delaware, Subject to Shareholder Approval"
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Benjamin Graham — 100/100
🔴 Weakest match
Morgan Housel — 19/100
🗣️ Why do they disagree?
This stock sparks a stark divide between methodologies that rely on fundamental valuation and those that emphasize market psychology or efficiency. Benjamin Graham’s defensive and enterprising frameworks both score perfectly, signaling a potential deep-value opportunity, while Charles Mackay’s absence of crowd mania further bolsters a contrarian case. In contrast, Fisher, Lynch, and Bagehot’s near-zero scores reflect a lack of actionable data for growth-driven or qualitative assessments, leaving their models neutral. Meanwhile, the mixed signals from Veblen, Malkiel/Bogle, and Loeb—ranging from uncertainty about profitability to moderate risk—highlight tensions between cyclical positioning and market efficiency. Marks’ mid-cycle assessment and Nelson’s oversold reading suggest a cautiously optimistic technical backdrop, while Housel’s low score warns of volatility that could deter patient investors, underscoring the stock’s polarizing appeal.
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟢 100
Attractive to a Defensive Graham Investor
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 100
Not enough dividend/growth data for a real Smith read
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟢 100
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 97
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 83
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 82
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 78
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 53
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 50
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 0%
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 45
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 43
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 41
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🔴 25
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 19
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 0
Not enough fundamentals data for a real Fisher read
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 20%
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 0
Not enough growth data for a real Lynch read
Key question
Is the growth worth the price?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Based on the last 283 trading days, calculated from real price data. Click an indicator for details and a chart.
🟡 Indicators are mixed — no clear bias (6 bullish · 5 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
—
EBITDA Margin
—
ROE
-4.1%
ROA
-0.4%
ROIC
—
EPS
-$0.84
Cash
$276.58M
Total Debt
—
Current Ratio
—
Debt/Equity
—
אין נתונים היסטוריים זמינים.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 6.5.2026 | $0.080 |
| 5.5.2026 | $0.080 |
| 11.2.2026 | $0.080 |
| 10.2.2026 | $0.080 |
| 10.11.2025 | $0.160 |
| 9.11.2025 | $0.160 |
| 11.8.2025 | $0.160 |
| 10.8.2025 | $0.160 |
| 7.5.2025 | $0.160 |
| 6.5.2025 | $0.160 |
| 7.2.2025 | $0.160 |
| 6.2.2025 | $0.160 |
How is Fair Value calculated? →
Current Price
$8.76
Estimated Fair Value (DCF)
$37.85
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+332.4%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
10.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 10.0% | $38.36M | $35.19M |
| 2 | 8.1% | $41.48M | $34.91M |
| 3 | 6.3% | $44.07M | $34.03M |
| 4 | 4.4% | $46.00M | $32.58M |
| 5 | 2.5% | $47.15M | $30.64M |
Base FCF (last actual year)
$34.87M
Terminal Value
$743.46M
Present Value of Terminal Value
$483.20M
Enterprise Value
$650.55M
Net Debt
$0
Equity Value
$650.55M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$17.71
Tangible Book Value per Share (Tangible NAV)
$17.71
Sentiment based on basic keywords (not AI) — 0 positive, 2 neutral, 18 negative out of the last 20 articles.
Benzinga · 21.9.2026
Yahoo · 20.9.2026
SeekingAlpha · 18.9.2026
Yahoo · 18.9.2026
Benzinga · 17.9.2026
Yahoo · 17.9.2026
Yahoo · 17.9.2026
Benzinga · 17.9.2026
Yahoo · 17.9.2026
Yahoo · 16.9.2026
Yahoo · 16.9.2026
SeekingAlpha · 7.9.2026
MT Newswires · 14.8.2026
Benzinga · 14.8.2026
Motley Fool · 11.8.2026
SeekingAlpha · 7.8.2026
Moby · 4.8.2026
MarketBeat · 3.8.2026
Zacks · 3.8.2026
Zacks · 3.8.2026
BCB Bancorp, Inc. (NJ) (BCBP) currently has a StockIQ AI score of 42/100, rated "Weak" (a partial score — based on only 6 of 7 categories, some data is currently unavailable). The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
BCBP currently scores 42/100 (Weak) across the categories we measure (a partial score — based on only 6 of 7 categories, some data is currently unavailable). StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, BCBP's estimated fair value is $37.85, which is 332.4% above the current price of $8.76. This is one valuation model among several signals in the fair-value category, not a price target.
BCBP's technical score is 49/100, which currently reads as neutral — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Estimated fair value: $37.85 vs. price $8.76 (+332.4%); MACD histogram is positive — rising momentum; NAV per share: $17.71.
Based on the real signals StockIQ computed: Calmar: -0.19 (3y annualized return -8.6% / max drawdown 45.3%); Return on equity (ROE): -4.1% (negative); Earnings per share (EPS) growth: -184.8%.
Yes — BCBP has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 6 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Werdann Gerald | Open Market Purchase | 4.6.2026 | 4,400 | +4,400 | $11.28 |
| Werdann Gerald | Open Market Purchase | 4.6.2026 | 12,122 | +4,400 | $11.28 |
| Blake Ryan | I | 3.6.2026 | 5,841 | -5,841 | $11.11 |
| Blake Ryan | I | 3.6.2026 | 1,112 | -5,841 | $11.11 |
| Werdann Gerald | Grant/Award from Employer | 22.4.2026 | 4,226 | +4,226 | $9.86 |
| Werdann Gerald | Grant/Award from Employer | 22.4.2026 | 4,226 | +4,226 | $9.86 |
| HOGAN MARK D | Open Market Purchase | 27.2.2026 | 5,000 | +5,000 | $7.97 |
| HOGAN MARK D | Open Market Purchase | 27.2.2026 | 103,352 | +5,000 | $7.97 |
| DiDomenico Vincent Jr | Grant/Award from Employer | 10.2.2026 | 5,952 | +5,952 | — |
| Rizzo James G. | Grant/Award from Employer | 10.2.2026 | 5,952 | +5,952 | — |
| LYGA JOSEPH | Grant/Award from Employer | 10.2.2026 | 5,952 | +5,952 | — |
| French Tara L | Grant/Award from Employer | 10.2.2026 | 5,952 | +5,952 | — |
| BIELAN JUDITH Q | Grant/Award from Employer | 10.2.2026 | 5,952 | +5,952 | — |
| Pulomena John | Grant/Award from Employer | 10.2.2026 | 5,952 | +5,952 | — |
| Widmer Michael J | Open Market Purchase | 10.2.2026 | 2,000 | +2,000 | $8.40 |
| HOGAN MARK D | Grant/Award from Employer | 10.2.2026 | 5,952 | +5,952 | — |
| Widmer Michael J | Grant/Award from Employer | 10.2.2026 | 5,952 | +5,952 | — |
| Widmer Michael J | Grant/Award from Employer | 10.2.2026 | 10,642 | +5,952 | — |
| Widmer Michael J | Open Market Purchase | 10.2.2026 | 12,642 | +2,000 | $8.40 |
| French Tara L | Grant/Award from Employer | 10.2.2026 | 13,142 | +5,952 | — |
| HOGAN MARK D | Grant/Award from Employer | 10.2.2026 | 627,092 | +5,952 | — |
| Pulomena John | Grant/Award from Employer | 10.2.2026 | 27,052 | +5,952 | — |
| LYGA JOSEPH | Grant/Award from Employer | 10.2.2026 | 187,695 | +5,952 | — |
| Rizzo James G. | Grant/Award from Employer | 10.2.2026 | 68,660 | +5,952 | — |
| BIELAN JUDITH Q | Grant/Award from Employer | 10.2.2026 | 120,504 | +5,952 | — |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
898,654 shares short as of 2026-08-31 · vs. 773,477 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
46.2% of trading volume this week was short selling, vs. 77.3% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology